Oncology PracticeDabrafenib may be useful in patients who discontinue vemurafenibJanuary 31, 2016Melanoma
Oncology PracticeOrgan transplant recipients face increased risk of BCCJanuary 31, 2016MelanomaPreventive CareNonmelanoma Skin CancerTransplant
Oncology PracticeMAPK inhibitor combo offers prolonged survival from BRAF+ advanced melanomaJanuary 25, 2016Melanoma
Oncology PracticeAnorectal melanoma rates rose significantly in 20-year analysisJanuary 22, 2016Melanoma
Oncology PracticeSirolimus reduced posttransplant skin cancer riskJanuary 20, 2016MelanomaTransplantNonmelanoma Skin CancerPreventive Care
Oncology PracticeEADV: Vismodegib treatment breaks don’t hurt efficacyJanuary 13, 2016MelanomaNonmelanoma Skin Cancer
Hematology NewsCancer prevention field riding high into the new yearJanuary 11, 2016Preventive CareMelanomaGynecologic CancerGI Oncology
Oncology PracticeFDA approves pembrolizumab as first-line advanced melanoma therapyDecember 23, 2015Melanoma
Oncology PracticeFDA proposes ban on indoor tanning for minorsDecember 18, 2015PediatricsPreventive CareMelanoma
The Journal of Community and Supportive OncologyEntering an era of intelligent combination therapy in cancerDecember 14, 2015Breast CancerLymphoma & Plasma Cell DisordersMelanomaImmunotherapy
The Journal of Community and Supportive OncologyOncology 2015: new therapies and new transitions toward value-based cancer careDecember 14, 2015Breast CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerPatient & Survivor CareLymphoma & Plasma Cell DisordersMelanoma
Oncology PracticeFDA approves treatment for chemotherapy ODs, life-threatening toxicitiesDecember 11, 2015GastroenterologyMelanomaGastrointestinal Cancer
